IT - EN
Pharmaceutical Operations

Pharmaceutical OperationsR & DPipeline

NAME ORIGINATOR INDICATION DEVELOPMENT STATUS
CYSTADROPS® Orphan Europe (Recordati) Corneal cysteine crystal deposits in patients with cystinosis Approved in EU in January 2017
FORTACIN™ Plethora Solutions Premature ejaculation Variation of EU approval completed
REAGILA® Gedeon Richter Schizophrenia Filed in EU
methadone   Treatment of cancer-related pain in cases of resistance or intolerance to opioids Filed in France
GRASPA® Erytech Acute lymphoblastic leukemia (ALL) in patients with first recurrence of Philadelphia chromosome negative ALL
 
Acute myeloid leukemia (AML) in patients >65 unfit for chemotherapy
Pre-filing in EU
 
 
 
Phase II b
CARBAGLU® Orphan Europe
(Recordati)
Hyperammonaemia due to NAGS deficiency and to the main organic acidemias Development of new formulations in EU and USA
Pre-filing in the USA for the organic acidemias indication
REC 0438 Recordati/UFPeptides Overactive bladder in patients with spinal lesions Phase I completed EU
REC 0545 Orphan Europe
(Recordati)/AP-HP
Acute decompensation episodes in MSUD Formulation development
Clinical development planning